IRIS UniCatt

Daniele, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.339
AS - Asia 5.849
EU - Europa 4.832
SA - Sud America 1.556
AF - Africa 265
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.095
SG - Singapore 2.498
IT - Italia 1.398
CN - Cina 1.293
BR - Brasile 1.236
DE - Germania 990
VN - Vietnam 699
SE - Svezia 646
FR - Francia 437
IE - Irlanda 282
GB - Regno Unito 220
ID - Indonesia 210
IN - India 185
JP - Giappone 184
BD - Bangladesh 181
UA - Ucraina 174
FI - Finlandia 169
AR - Argentina 150
RU - Federazione Russa 148
HK - Hong Kong 138
CI - Costa d'Avorio 113
CA - Canada 103
MX - Messico 85
PL - Polonia 77
TR - Turchia 76
IQ - Iraq 71
NL - Olanda 51
ES - Italia 50
KR - Corea 50
ZA - Sudafrica 48
AT - Austria 46
EC - Ecuador 41
PK - Pakistan 36
VE - Venezuela 33
CO - Colombia 32
BE - Belgio 31
SA - Arabia Saudita 26
UZ - Uzbekistan 21
AU - Australia 20
PE - Perù 20
TW - Taiwan 20
JO - Giordania 19
TN - Tunisia 18
MA - Marocco 15
MY - Malesia 15
NP - Nepal 15
CL - Cile 14
EG - Egitto 14
IR - Iran 14
AE - Emirati Arabi Uniti 13
KE - Kenya 13
PH - Filippine 13
PT - Portogallo 13
IL - Israele 12
JM - Giamaica 12
PY - Paraguay 12
RO - Romania 12
AZ - Azerbaigian 11
CH - Svizzera 11
CZ - Repubblica Ceca 11
RS - Serbia 11
UY - Uruguay 11
DO - Repubblica Dominicana 10
DZ - Algeria 10
ET - Etiopia 9
LB - Libano 9
AL - Albania 7
LT - Lituania 7
BO - Bolivia 6
GR - Grecia 6
NO - Norvegia 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
HN - Honduras 5
OM - Oman 5
PS - Palestinian Territory 5
BG - Bulgaria 4
HR - Croazia 4
KZ - Kazakistan 4
MD - Moldavia 4
PA - Panama 4
QA - Qatar 4
SV - El Salvador 4
AM - Armenia 3
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
GT - Guatemala 3
LK - Sri Lanka 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
BZ - Belize 2
CG - Congo 2
CY - Cipro 2
EU - Europa 2
GA - Gabon 2
NG - Nigeria 2
PR - Porto Rico 2
Totale 18.830
Salva come PNG Salva come JPEG
Città #
Singapore 1.215
San Jose 752
Ashburn 690
Chandler 623
Beijing 277
Dublin 258
Ho Chi Minh City 244
Hanoi 181
Jakarta 173
Lauterbourg 172
Rome 172
Tokyo 168
Hefei 160
New York 132
Milan 130
Hong Kong 124
Los Angeles 124
Wilmington 124
San Mateo 123
Abidjan 113
Jacksonville 112
Dallas 111
Nanjing 109
Boston 105
São Paulo 105
Dearborn 102
Cambridge 97
Princeton 94
Frankfurt am Main 92
Ann Arbor 90
Helsinki 80
St Louis 79
Moscow 78
Council Bluffs 75
Cattolica 66
Woodbridge 64
Redwood City 61
Warsaw 61
Fairfield 60
Chicago 50
Seattle 50
The Dalles 49
Houston 48
Nürnberg 48
Kent 46
Naples 45
Tukwila 45
Boardman 44
Nuremberg 44
Seoul 42
Munich 41
Rio de Janeiro 41
Nanchang 39
Da Nang 38
Santa Clara 38
Redmond 35
Buffalo 34
Shanghai 34
Atlanta 33
Chennai 33
Lawrence 33
London 33
Marseille 33
Paris 33
Brooklyn 32
Guangzhou 31
Bari 30
Shenyang 29
Curitiba 28
Bremen 27
Izmir 27
Montreal 27
Brasília 26
Norwalk 26
Orem 26
Turku 26
Changsha 25
Baghdad 24
Hangzhou 24
Belo Horizonte 23
Mountain View 23
Toronto 23
Brussels 22
Vienna 21
Amsterdam 20
Campinas 20
Kunming 20
Phoenix 20
Tianjin 20
Amman 19
Denver 19
Dhaka 19
Lappeenranta 19
Biên Hòa 18
Johannesburg 18
Mexico City 18
Haiphong 17
Hebei 17
Lancaster 17
Tashkent 17
Totale 9.423
Salva come PNG Salva come JPEG
Nome #
Neuropsichiatria dei disturbi dell’umore. In: Neuroscienze cliniche e del comportamento. Basi neurobiologiche e neuropsicologiche. Psicopatologia funzionale e neuropsichiatria A cura di C. Blundo 583
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 365
Basi neuro anatomiche delle funzioni cognitive e del comportamento 248
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 222
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 215
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 205
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 201
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 194
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 192
Sexual Behavior in Women with Bipolar Disorder 187
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 176
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 172
New insights into the genetic etiology of Alzheimer's disease and related dementias 169
Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life 165
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 165
Oxidative Stress And Overexpression Of Manganese Superoxide Dismutase In Patients With Alzheimer's Disease. 161
Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease 161
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 161
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 159
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging. 157
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 152
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 151
Oral frailty and its determinants in older age: a systematic review 146
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 145
APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women 145
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial 144
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 144
Suicidal behaviour in older age: A systematic review of risk factors associated to suicide attempts and completed suicides 143
Analysis of blink rate in patients with blepharospasm 141
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 139
Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis 138
Polymorphism C in the serotonin 1 transporter gene in depression-free elderly patients with vascular dementia 138
Contribution of Mediterranean Diet in the Prevention of Alzheimer's Disease. 136
Disproportionate Impairment in Naming and Comprehension of Nouns with Relative Sparing of Verbs in a Patient who Survived Herpes Simplex Encephalitis 136
Cognitive and behavioural changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 132
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease 132
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 131
The potential of solanezumab and gantenerumab to prevent Alzheimerâ s disease in people with inherited mutations that cause its early onset 131
Spinal cord stimulation may improve gait and cognition in hereditary spastic paraplegia with mental retardation: a case report 130
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know? 129
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 129
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 127
An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-Term Care Facilities 126
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 126
Neuropsychological features of patients with Parkinson’s disease and impulse control disorders 124
Social Frailty in the COVID-19 Pandemic Era 124
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 123
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 123
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 121
Neuroanatomical Correlates of Category-specific Semantic Disorders: A Critical Survey 121
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 121
Accelerated Long-Term Forgetting Limited to the Recollection Component of Recognition Memory in a Temporal Lobe Epileptic Patient 119
The RELN locus in Alzheimer's Disease 119
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 116
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 115
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease 112
Apolipoprotein E ε4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients 112
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease? 111
Early rightwards orienting of attention on simple reaction time performance in patients with left-sided neglect 109
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 108
Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease 108
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 107
Malattia di Parkinson e altri disordini del movimento 107
Cognitive frailty: definitions, components, and impact on disability and mortality 106
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 105
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 104
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 103
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 103
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 102
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs 102
The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes 102
Cognitive frailty: a potential target for secondary prevention of dementia 101
The missing ApoE allele 101
Intraoperative Local Field Potential Beta Power and Three-Dimensional Neuroimaging Mapping Predict Long-Term Clinical Response to Deep Brain Stimulation in Parkinson Disease: A Retrospective Study 100
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease 100
FOXP2, APOE, and PRNP: New Modulators in Primary Progressive Aphasia 100
Genotypes and haplotypes in the IL-1 gene cluster: Analysis of two genetically and diagnostically distinct groups of Alzheimer patients 100
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders 99
ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer's disease 98
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 98
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia 96
The role of biomarkers in psychiatry 96
Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism 96
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs 96
Physical Frailty, Multimorbidity, and All-Cause Mortality in an Older Population From Southern Italy: Results from the Salus in Apulia Study 95
Oral frailty indicators and cardio- and cerebrovascular diseases in older age: A systematic review 94
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 94
Normal pressure hydrocephalus 93
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 92
The need of an extensive neuropsychological assessment for a reliable diagnosis of mild cognitive impairment in patients with Parkinson's disease 91
Targeting oral frailty indicators of late-life cognitive disorders and depression: a systematic review 90
Zolpidem in Parkinson's disease 90
APOE ε2-ε4 genotype is a possible risk factor for primary progressive aphasia [6] 89
Oral frailty and neurodegeneration in Alzheimer's disease 89
The diagnostic accuracy of late-life depression is influenced by subjective memory complaints and educational level in an older population in Southern Italy 89
Oral health indicators and bone mineral density disorders in older age: A systematic review 88
Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation 88
Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders 87
Corrigendum to "Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review" Neurosci. Biobehav. Rev. 95 (2018) 480-498 86
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease? 86
Totale 13.298
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/20221.095 80 73 31 71 112 51 28 151 65 53 172 208
2022/20232.086 229 235 170 227 181 258 187 145 249 72 62 71
2023/20241.315 72 362 61 61 75 124 117 51 32 46 147 167
2024/20252.690 56 54 197 105 146 106 75 133 433 277 607 501
2025/20268.777 1.260 267 748 1.198 1.150 400 1.263 500 598 743 395 255
Totale 19.436